Abstract 1025: Primary safety and effectiveness outcomes of the prospective international multicenter STERLING intracranial aneurysm coiling registry
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von O. Zaidat und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction/Purpose: Intracranial aneurysms (IAs) are vascular lesions that can lead to subarachnoid hemorrhage (SAH) if ruptured. Endovascular coils exclude the lesion from circulation to reduce the risk of SAH and mortality. The STERLING (NCT03642639) registry evaluated real-world safety and effectiveness of MICRUSFRAME and GALAXY coils for endovascular treatment of IAs. The aim of the current study was to present long-term safety and effectiveness outcomes from the STERLING registry. Materials/Methods: STERLING was a prospective, multi-center, single-arm study in which eligible participants with ruptured or unruptured IAs underwent endovascular coiling with ≥75% study device coils by length, with or without adjunctive devices. The primary end point was adequate occlusion (MRRC I or II) of the target IA without retreatment at end of study (EOS; 1 year [-3 months/+1.5 years] post-procedure). Secondary end points included complete occlusion, recanalization rate, retreatment rate, good clinical outcome (modified Rankin Score ≤2) among participants with unruptured IAs, packing density, and device-related serious adverse events (SAEs).
Results
Of 723 enrolled participants, 703 were evaluated for safety and 493 were evaluated for effectiveness. At EOS, adequate without retreatment and complete occlusion were achieved by 87.0% (95% confidence interval [CI], 83.7%-89.9%) and 76.1% (95% CI, 72.0%-79.8%) of participants, respectively. Recanalization and retreatment rates at EOS were 10.5% (95% CI, 8.0%-13.6%) and 7.0% (95% CI, 5.1%-9.7%), respectively. Of participants with unruptured IAs (332/338), 98.2% (95% CI, 96.2%-99.3%) achieved good clinical outcome at EOS. Mean (SD) packing density was 28.2% (12.7%). Device-related SAE by EOS was 2.7% (95% CI, 1.7%-4.3%).
Conclusion
We report on the real-life efficacy and safety of the coils through a large international multicenter registry.
Zitieren
APA
Zaidat, O., Yoo, A., Mamat, G., Starke, R. M., Puri, A., Jankowitz, B., Woodward, B. K., Kulcsar, Z., Machi, P., Jahshan, S., Sugiu, K., Kilburg, C., Castro, S., & Leacy, R. D. (2026). Abstract 1025: Primary safety and effectiveness outcomes of the prospective international multicenter STERLING intracranial aneurysm coiling registry. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1025
Vancouver
Zaidat O, Yoo A, Mamat G, Starke RM, Puri A, Jankowitz B, et al. Abstract 1025: Primary safety and effectiveness outcomes of the prospective international multicenter STERLING intracranial aneurysm coiling registry. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1025
BibTeX
@article{Zaidat2026,
author = {Zaidat, O. and Yoo, A. and Mamat, G. and Starke, R. M. and Puri, A. and Jankowitz, B. and Woodward, B. K. and Kulcsar, Z. and Machi, P. and Jahshan, S. and Sugiu, K. and Kilburg, C. and Castro, S. and Leacy, R. D.},
title = {Abstract 1025: Primary safety and effectiveness outcomes of the prospective international multicenter STERLING intracranial aneurysm coiling registry},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1025}
}
EUVIMED